Intensive antiplatelet therapy did not reduce recurrent stroke/transient ischaemic attack (TIA)
events as compared with guideline treatment in the Triple Antiplatelets for Reducing …

Background Intensive antiplatelet therapy with three agents might be more effective than
guideline treatment for preventing recurrent events in patients with acute cerebral …

Rationale Antiplatelet agents such as aspirin, clopidogrel and dipyridamole are effective in
reducing the risk of recurrence after a stroke. Importantly, the risk of recurrence is highest …

Rationale The risk of recurrence following a stroke or transient ischemic attack is high,
especially immediately after the event. Hypothesis Because two antiplatelet agents are …

Objective To study the early time course of major bleeding and its subtypes in patients with
cerebral ischemia on dual and single antiplatelet therapy. Methods We performed a post hoc …

Background: Evidence about the use of dual antiplatelet therapy (DAPT) with aspirin and
P2Y12 inhibitors in patients with acute minor ischemic stroke or transient ischemic attack …

Background The risk of recurrence following ischemic stroke or transient ischemic attack is
highest immediately after the event. Antiplatelet agents are effective in reducing the risk of …

Patients with minor ischemic stroke or a high-risk transient ischemic attack (TIA) face a high
risk of recurrent stroke or other vascular events. The risk is particularly high in the first few …

Background Antiplatelet therapy reduces the risk of major vascular events for people with
occlusive vascular disease, although it might increase the risk of intracranial haemorrhage …

Background: Two recent cerebrovascular studies, Clopidogrel (Clo) in High-risk patients
with Acute Nondisabling Cerebrovascular Events (CHANCE) and Platelet-Oriented …